Navigation Links
Support cells, not neurons, lull the brain to sleep
Date:1/28/2009

n shown to influence behavior. Unlike neurons, astrocytes do not fire electrical spikes, and they are often described as support cells.

In experiments on mice, Dr. Halassa and his colleagues used a genetic switch, called the dnSNARE transgene, to block the release of adenosine and other chemicals from astrocytes. The researchers then deprived the mice of sleep for short periods, and evaluated them with behavioral tests and with electroencephalography (EEG), a means of recording brain activity.

Mice subjected to the genetic blockade exhibited less sleep pressure than control mice. Following sleep deprivation, they did not need as much compensatory sleep, and during the early phases of sleep, they had patterns of brain activity consistent with low sleep pressure. When they were evaluated with a memory test, they performed as if their sleep had been undisturbed.

The researchers observed similar results when they used certain compounds to block the effects of adenosine on neurons. Neurons have several types of cell-surface receptors that enable them to respond to adenosine, but only pharmacological blockade of the A1 type of receptor was effective. That result shows that adenosine acts through the A1 receptor to produce sleep pressure.

Taken together, the results hint at the possibility of new drugs that could increase or decrease sleep pressure as necessary. The best available sleep aids tend to be effective at inducing sleep, but not effective at keeping it steady throughout the night. Meanwhile, the most commonly used stimulant, caffeine, acts on multiple types of adenosine receptors, and can affect sleep patterns even when it is consumed in the morning. Drugs that target astrocytes or the A1 receptors on neurons might be more effective at fine-tuning the urge to sleep, the study authors say.

The dnSNARE mice also will prove useful for answering some long-standing questions about sleep, experts say. For instanc
'/>"/>

Contact: Daniel Stimson
stimsond@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Purkinje Announces EMR Promotions in Support of National Healthcare Reform Initiatives
2. Call- Shadow IP Call Management Software, V.5. Now 64 bit with SIP and Enhanced Platform Support
3. Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education
4. Lance Armstrong Foundation Selects Ogilvy Public Relations Worldwide to Support the LIVESTRONG Global Cancer Campaign
5. Impac Software Announces Clinical Release of RapidArc Support
6. Technology Leaders Call on Congress to Support Investments in Digital Infrastructure as Part of Economic Stimulus and Recovery Plan
7. Grassroots Group Gets Travel Advantage Network Support
8. Developing countries need support to ethically conduct unlinked anonymous HIV testing
9. The Quantum Group Announces Support of Technology Bill Before Congress
10. Seattle Reproductive Medicine Study Investigates Newly Formulated Medications for Luteal Support in IVF
11. National Council of Legislators From Gaming States Adopts Resolution Supporting 100% Smokefree Gaming Venues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Lawrenceville, Georgia (PRWEB) , ... September 03, 2015 ... ... the spread of disease in Haiti, has partnered with Slingshot® Product Development Group ... no electricity or running water. Michael Wahl with DriButts plans to bring 600 ...
(Date:9/3/2015)... ... ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain ... an official endorsement deal with the company. Originally from New South Wales, Australia, Mason ... 15. He is an Australian bull riding champion, following in his uncles’ footsteps in ...
(Date:9/3/2015)... Tamarac, FL (PRWEB) , ... September 03, 2015 ... ... of the Florida Companies to Watch for 2015 by economic development ... one of only 50 companies in the state selected for this prestigious award, ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... estate investment landscape by connecting accredited and institutional investors to real estate investment ... products designed to meet demand from both investors and sponsoring real estate companies. ...
(Date:9/3/2015)... ... ... Girl’s Night Out to benefit Core Compassion Project will be held on ... Monroe, North Carolina. The event food will be provided by Kate Clyde's ... off-premise catering and event services from casual to elegant. They are also the home ...
Breaking Medicine News(10 mins):Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2
... stray cancer cells lurking elsewhere in the body that otherwise ... study in the June 13 issue of the journal ... most may have such indolent cancer cells given the sheer ... them impossible to detect, the researchers said. , The ...
... his famous poem, "Do not go gentle into that good ... dying of the light." Researchers are now backing up this ... to one,s health is critical to good health and survival ... the notion that one should become actively involved in one,s ...
... Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that it ... its Trofex molecular imaging program for the detection ... is designed to investigate two small molecule radiopharmaceutical ... and MIP-1095, in order to select a lead ...
... Foundation, a,nonprofit organization that funds research in early ... five recipients of its Canary,Foundation and American Cancer ... during Canary Foundation,s Early,Detection Symposium in May, the ... of fellows sponsored since the program,s inception in,2004. ...
... supports Courage Center Camps, MINNEAPOLIS, June 12 The ... 2008, at the St. Cloud Country Club. Golfers,will enjoy a ... a,great cause -- Courage Center,s Camp Courage., Registration and ... 1 p.m.,Cost per golfer is $150 or $600 for a ...
... and Life Sciences Customers the DICOM ... EMC Select, ST. PAUL, Minn., June 12 ... grid software for,intelligent medical image management, DICOM and storage ... announced that its DICOM,Services Grid is now available through ...
Cached Medicine News:Health News:Primary tumors can drive the growth of distant cancers 2Health News:Primary tumors can drive the growth of distant cancers 3Health News:Study pinpoints strategies that protect older adult's physical health 2Health News:Molecular insight begins Trofex Ph. 1 trial for detection of metastatic prostate cancer 2Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 2Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 3Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 4Health News:DICOM Services Grid(TM) From Acuo Technologies(R) Available Through EMC Select 2
(Date:9/3/2015)... Sept. 3, 2015 China,s ... Fetus Monitoring Patch, a wearable medical device that can ... movement data, providing safety guidance for pregnant women. The ... The device, which measures 4 centimeters in diameter, ... a little more than an Apple earphone cord. The ...
(Date:9/3/2015)... , Sept. 3, 2015 HeartWare International, ... of less invasive, miniaturized circulatory support technologies that are ... that its President and Chief Executive Officer, Doug ... Wells Fargo Healthcare Conference at 8:50 a.m. ET on ... 9-10, 2015 at The Hyatt Regency, Boston ...
(Date:9/3/2015)... , Sept. 3, 2015  The findings of a ... disturbing questions about the company,s handling of its ... On September 2 nd , part one of ... events, including at least 27 fatalities, have been associated ... confidential study commissioned by C.R. Bard in 2004 which ...
Breaking Medicine Technology:Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3
... to be Presented for Phase 2 Colorectal and Prostate ... May 31 with Oncology Experts - SOUTH SAN FRANCISCO, ... PARD ) today announced that the Company will ... trials of picoplatin, the Company,s lead product candidate, at ...
... This Trial to be Presented at ASCO--First Phase ... Patient Enrollment-TUSTIN, Calif., May 4 Peregrine Pharmaceuticals, ... it has completed enrollment in its Phase II ... advanced breast cancer patients. The planned 46 ...
Cached Medicine Technology:Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 2Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 3Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 4Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients 2Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients 3Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: